تلخیص
Objectives: This randomized controlled trial was performed to examine the effectiveness of Helicobacter pylori max regime,
a traditional medicine preparation, among duodenal ulcer patients with Helicobacter pylori infection.
Material & Methods: The intervention group (n = 42) used Helicobacter pylori max regimen and the control group (n = 43)
used Omeprazole, Amoxicillin and Clarithromycin (OAC) regimen.
Results: The number of patients having type A pain relief in intervention group (33.3%) was higher than that in control group
(23.3%) (p> 0.05). There were 59.5% patients in the intervention group not having Helicobacter Pylori after treatment, which
was lower than that of control group (69.8%) (p> 0.05). The rate of complete healing in the HP max group reached 68.2%,
equivalent to the rate of complete healing in the patients using OAC (71.1%) (p> 0.05). No serious adverse effects were
observed in these two groups.
Conclusion: These findings depicted the potential of HP max in clinical settings in order to reduce the burden of duodenal
ulcers with H. pylori infection.